Literature DB >> 18541142

Thrombospondin-4 expression is rapidly upregulated by cardiac overload.

Erja Mustonen1, Jani Aro, Jutta Puhakka, Mika Ilves, Ylermi Soini, Hanna Leskinen, Heikki Ruskoaho, Jaana Rysä.   

Abstract

The precise mechanisms regulating gene expression of thrombospondins (TSPs) in the heart remain incompletely understood. Here we characterized cardiac TSP-4 expression in response to pressure overload and myocardial infarction in vivo. Arginine(8)-vasopressin (AVP) infusion increased left ventricular (LV) TSP-4 mRNA levels within 30 min. Also angiotensin II infusion rapidly activated LV TSP-4 expression, TSP-4 mRNA levels being highest at 6h and protein at 72 h and 2 weeks. During remodeling process following myocardial infarction, LV TSP-4 mRNA levels increased at day one, as studied by quantitative RT-PCR. TSP-4 immunostaining was localized to endothelial cells in hypertrophied hearts of spontaneously hypertensive rats. AVP-infusion increased LV TSP-1 mRNA levels similarly to TSP-4 within 30 min showing that rapid induction of gene expression, well before the development of cardiac hypertrophy, is typical for the thrombospondin family. These results further suggest that TSP-4 may be an endothelial specific marker of cardiac overload.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541142     DOI: 10.1016/j.bbrc.2008.05.164

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Thrombospondins in the transition from myocardial infarction to heart failure.

Authors:  Jonathan A Kirk; Oscar H Cingolani
Journal:  J Mol Cell Cardiol       Date:  2015-12-10       Impact factor: 5.000

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 3.  The extracellular matrix in myocardial injury, repair, and remodeling.

Authors:  Nikolaos G Frangogiannis
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

4.  Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload.

Authors:  Ella G Frolova; Nikolai Sopko; Lauren Blech; Zoran B Popovic; Jianbo Li; Amit Vasanji; Carla Drumm; Irene Krukovets; Mukesh K Jain; Marc S Penn; Edward F Plow; Olga I Stenina
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

5.  Thrombospondin-4 is required for stretch-mediated contractility augmentation in cardiac muscle.

Authors:  Oscar H Cingolani; Jonathan A Kirk; Kinya Seo; Norimichi Koitabashi; Dong-Ik Lee; Genaro Ramirez-Correa; Djahida Bedja; Andreas S Barth; An L Moens; David A Kass
Journal:  Circ Res       Date:  2011-10-27       Impact factor: 17.367

6.  Control of organization and function of muscle and tendon by thrombospondin-4.

Authors:  Ella G Frolova; Judith Drazba; Irene Krukovets; Volodymyr Kostenko; Lauren Blech; Christy Harry; Amit Vasanji; Carla Drumm; Pavel Sul; Guido J Jenniskens; Edward F Plow; Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-03-01       Impact factor: 11.583

Review 7.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

8.  ATF6 [corrected] and thrombospondin 4: the dynamic duo of the adaptive endoplasmic reticulum stress response.

Authors:  Shirin Doroudgar; Christopher C Glembotski
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

Review 9.  Extracellular matrix-mediated cellular communication in the heart.

Authors:  Iñigo Valiente-Alandi; Allison E Schafer; Burns C Blaxall
Journal:  J Mol Cell Cardiol       Date:  2016-01-14       Impact factor: 5.000

10.  Thrombospondins in the heart: potential functions in cardiac remodeling.

Authors:  Mark W M Schellings; Geert C van Almen; E Helene Sage; Stephane Heymans
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.